Metabolic responses to tumour disease and progression: tumour-host interaction.
The progressive nutritional deterioration frequently found in cancer patients, is often referred to as cancer cachexia. In contrast to starvation, where it is possible to reverse the body composition changes by the provision of extra calories, in cancer cachexia this reversal is not observed, suggesting that anorexia alone is unlikely to be responsible for this wasting syndrome. Over the past decades a number of studies have focused on the possible mediators which may be responsible for metabolic abnormalities observed in cancer patients. Pro-inflammatory cytokines have been strongly implicated, but evidence supporting such a direct role is lacking. Recently, exciting work regarding molecules produced by tumour cells, and which may induce lipolysis and proteolysis, has been published. There is also evidence that increased metabolism of host resources may provide substrates which might promote tumour growth. A number of studies have demonstrated that polyunsaturated fatty acids, such as linoleic and arachidonic acid, are able to promote tumour cell growth either by directly stimulating mitosis or by inhibiting apoptosis. Even more interesting is the discovery of antagonists of these catabolic factors such as eicosapentanoic acid for the lipolytic factor, which may play a role in the treatment of these patients in the near future.
Cravo
M L
ML
Serviço de Gastrenterologia, Instituto Português de Oncologia Francisco Gentil (Centro Regional de Lisboa), Lisbon, Portugal.
Glória
L M
LM
Claro
I
I
D002100:Cachexia / Q000209:etiology / Q000378:metabolism*; D050260:Carbohydrate Metabolism; D004734:Energy Metabolism; D006801:Humans; D050356:Lipid Metabolism; D009369:Neoplasms / Q000150:complications* / Q000178:diet therapy / Q000378:metabolism*; D011506:Proteins / Q000378:metabolism
D011506:Proteins